Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System

Clinical trial NCT05437679 · TERMINATED

Trial details

NCT number: NCT05437679
Sponsor: Angle plc
Status: TERMINATED
Study type: OBSERVATIONAL

High Risk Prostate Carcinoma Biochemically Recurrent Prostate Carcinoma Castration-resistant Prostate Cancer Prostate Cancer

Start date: 2022-07-05
Primary completion: 2023-08-22
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.